Ligand Pharmaceuticals Inc financial data

Symbol
LGND on Nasdaq, LGNDZ, LGNXZ, LGNYZ, LGNZZ on OTC
Industry
Pharmaceutical Preparations
Location
3911 Sorrento Valley Blvd, Suite 110, San Diego, CA
State of incorporation
DE
Fiscal year end
December 31
Former names
LIGAND PHARMACEUTICALS (to 9/13/1994)
Latest financial report
10-Q - Q3 2024 - Nov 8, 2024

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 1.58K % +241%
Quick Ratio 104 % +216%
Debt-to-equity 12.8 % -37.3%
Return On Equity 5.79 % +126%
Return On Assets 5.14 % +142%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18.9M shares +8.37%
Common Stock, Shares, Outstanding 18.8M shares +7.69%
Entity Public Float 900M USD -10%
Common Stock, Value, Issued 19K USD +5.56%
Weighted Average Number of Shares Outstanding, Basic 18.4M shares +5.98%
Weighted Average Number of Shares Outstanding, Diluted 18.4M shares +5.98%

Income Statement

Label TTM Value / Value Unit Change %
Revenue from Contract with Customer, Excluding Assessed Tax 152M USD -0.76%
Research and Development Expense 22.5M USD -20.4%
General and Administrative Expense 69M USD +1.64%
Operating Income (Loss) -16.3M USD -240%
Nonoperating Income (Expense) 75.1M USD -0.48%
Income (Loss) from Continuing Operations before Income Taxes, Noncontrolling Interest 58.8M USD -16.8%
Income Tax Expense (Benefit) 13.6M USD -72.6%
Net Income (Loss) Attributable to Parent 45.2M USD +175%
Earnings Per Share, Basic 2.61 USD/shares +172%
Earnings Per Share, Diluted 2.55 USD/shares +207%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value 63.6M USD +230%
Accounts Receivable, after Allowance for Credit Loss, Current 34.3M USD -4.68%
Inventory, Net 16.7M USD -34.1%
Other Assets, Current 19.7M USD +841%
Assets, Current 309M USD +21.8%
Deferred Income Tax Assets, Net 78K USD -99.1%
Property, Plant and Equipment, Net 15.1M USD -6.7%
Operating Lease, Right-of-Use Asset 7.16M USD +14.8%
Intangible Assets, Net (Excluding Goodwill) 275M USD -12.7%
Goodwill 105M USD +1.43%
Other Assets, Noncurrent 8.4M USD -0.26%
Assets 955M USD +24.1%
Accounts Payable, Current 4.69M USD +89.7%
Employee-related Liabilities, Current 3.83M USD +32.5%
Accrued Liabilities, Current 15.6M USD +46.7%
Contract with Customer, Liability, Current 1.15M USD
Liabilities, Current 24.8M USD +57.5%
Contract with Customer, Liability, Noncurrent 15.3M USD
Deferred Income Tax Liabilities, Net 46.4M USD +42.4%
Operating Lease, Liability, Noncurrent 6.27M USD +7.46%
Other Liabilities, Noncurrent 29.9M USD -31.6%
Liabilities 114M USD +12.2%
Accumulated Other Comprehensive Income (Loss), Net of Tax 1.75M USD
Retained Earnings (Accumulated Deficit) 530M USD +9.33%
Stockholders' Equity Attributable to Parent 841M USD +25.9%
Liabilities and Equity 955M USD +24.1%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities 18.7M USD -44.8%
Net Cash Provided by (Used in) Financing Activities 12.2M USD
Net Cash Provided by (Used in) Investing Activities -3.78M USD -136%
Common Stock, Shares Authorized 60M shares 0%
Common Stock, Shares, Issued 18.8M shares +7.69%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect 27.1M USD -37.9%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents 63.6M USD +220%
Interest Paid, Excluding Capitalized Interest, Operating Activities 59K USD
Deferred Tax Assets, Valuation Allowance 57.7M USD +0.4%
Deferred Tax Assets, Gross 104M USD -6.5%
Operating Lease, Liability 6.16M USD -44%
Payments to Acquire Property, Plant, and Equipment 105K USD -95.7%
Comprehensive Income (Loss), Net of Tax, Attributable to Parent 47.9M USD +189%
Lessee, Operating Lease, Liability, to be Paid 8.82M USD -42.7%
Property, Plant and Equipment, Gross 22.3M USD -1.53%
Operating Lease, Liability, Current 1.07M USD +114%
Lessee, Operating Lease, Liability, to be Paid, Year Two 1.19M USD -19.6%
Lessee, Operating Lease, Liability, to be Paid, Year One 1.05M USD -26.6%
Operating Lease, Weighted Average Discount Rate, Percent 0.08 pure +14.1%
Lessee, Operating Lease, Liability, Undiscounted Excess Amount 2.24M USD -48.9%
Lessee, Operating Lease, Liability, to be Paid, Year Three 1.23M USD -22.2%
Deferred Tax Assets, Operating Loss Carryforwards 45.7M USD -15.3%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 5M shares 0%
Unrecognized Tax Benefits 14.5M USD
Lessee, Operating Lease, Liability, to be Paid, Year Four 1.26M USD -22.3%
Additional Paid in Capital 309M USD +68.1%
Preferred Stock, Shares Outstanding 0 shares
Depreciation, Depletion and Amortization 8.77M USD -7.73%
Deferred Tax Assets, Net of Valuation Allowance 46.1M USD -13.9%
Interest Expense 557K USD -55.4%
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%